Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML

MeSH terms

• Acute Disease
• Adolescent
• Adult
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• CCAAT-Enhancer-Binding Protein-alpha / genetics*
• Clinical Trials as Topic / statistics & numerical data
• Disease-Free Survival
• Female
• Humans
• Leukemia, Myeloid / drug therapy
• Leukemia, Myeloid / genetics*
• Leukemia, Myeloid / mortality
• Male
• Middle Aged
• Mutagenesis, Insertional
• Neoplasm Proteins / genetics*
• Polymorphism, Genetic*
• Prognosis
• Protein Structure, Tertiary
• Risk
• Survival Analysis